Trial Profile
Observational Cohort Study of First line Bevacizumab with Oxaliplatin or Irinotecan and Fluoropyrimidines in Metastatic Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 04 Aug 2015 New trial record